Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa I16L-Reference-Cited by-同舟云学术

Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa I16L

Published:2017-08 Issue:8 Volume:106 Page:2136-2143
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Parng Chuenlei,Markiewicz Victoria,Chen Jianqing,Leary Beth,Duriga Nicole,Dyleski Lisa,Caiazzo Teresa,Bolt Michael,Joyce Alison,Gorovits Boris,Pittman Debra D.,Webster Robert

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. FXa variants advance toward a therapy for bleeding;Jonas;Blood,2015

2. The conformational switch from the factor X zymogen to protease state mediates exosite expression and prothrombinase assembly;Toso;JBC,2008

3. Zymogen-like factor Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in vitro;Bunce;Blood,2011

4. Correction of the coagulation defect in hemophilia using a factor Xa variant with novel engineered protease function;Ivanciu;Nat Biotechnol,2011

5. Correction of human hemophilia A whole blood abnormalities with a novel bypass agent: zymogen-like FXaI16L;George;J Thromb Haemost,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latest advances in the reversal strategies for direct oral anticoagulants;Fundamental & Clinical Pharmacology;2024-02-13

2. Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics;Journal of Thrombosis and Thrombolysis;2021-04-22

3. Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis;Thrombosis Research;2021-02

4. Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies;Seminars in Thrombosis and Hemostasis;2020-07-20

5. A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A;Thrombosis and Haemostasis;2019-10-22